CompanyDrug

Eli Lilly’s Olumiant Patent Invalidated in China, Generic Version Approved

CompanyDrug

BMS’s Opdivo-Yervoy Combo Cuts Cancer Progression Risk by 79% in Phase III Study

CompanyDrug

Tcelltech’s B7-H3 Targeting CAR-T Therapy TX103 Gets Tacit Clinical Approval for Glioblastoma

CompanyDrug

Merck’s Bavencio Shows Promising Survival Data in Real-World Urothelial Carcinoma Studies

CompanyDrug

BriSTAR Immunotech’s LILRB4-Targeted Cell Therapy YTS104 Gets Tacit Approval for Clinical Trial in China

Company

Biocytogen Launches RenBiologics Sub-brand to Expand Antibody Discovery Business

CompanyDeals

Shanghai’s Reunion Biotech Secures Series B Funding to Advance Hydrogel Products

CompanyDrug

Legend Biotech’s Carvykti Files for European Approval as Second-Line MM Treatment

CompanyDeals

Beijing Sun-Novo and Zhejiang Anglikang Deepen Ties with New Drug Development Partnership

CompanyDeals

WuXi XDC Partners with Celltrion to Support Global Development and Manufacturing of Bioconjugated Drugs

CompanyDrug

Visirna Therapeutics Completes Enrollment in Phase III Study for FCS Drug VSA001

CompanyDeals

Shanghai Pharmaceutical and Sino Biopharmaceutical Form Strategic Partnership for Pharmaceutical Services